stockrowGlobus Medical, Inc.
GMED Healthcare Medical Devices
Globus Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 16.7% from fiscal 2024.
- Revenue
- −0.69%
- EPS
- +19.3%
- Free cash flow
- +10.1%
Quarter to September 2026, against a year earlier
Follow GMED
Alert me
Globus Medical, Inc. (GMED) Free cash flow
Globus Medical, Inc.'s free cash flow for fiscal 2025 was $579.0M, up 42.9% from $405.2M in fiscal 2024. Over the twelve months to 30 September 2026 it was $766.6M. Over the past ten years it has ranged from $73.2M (fiscal 2015) to $579.0M (fiscal 2025) — the current reading is the highest in ten years. Free cash flow has risen for 3 consecutive fiscal years. Globus Medical, Inc. ranks 12th of 149 Medical Devices companies by free cash flow.
Free cash flow, annual
Embed this chart
Annual newest first
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | $579.0M | 42.89% |
| FY2024 | $405.2M | 145.25% |
| FY2023 | $165.2M | 58.23% |
| FY2022 | $104.4M | (52.40%) |
| FY2021 | $219.4M | 62.34% |
| FY2020 | $135.1M | 33.50% |
| FY2019 | $101.2M | (20.26%) |
| FY2018 | $126.9M | 17.81% |
| FY2017 | $107.8M | 0.79% |
| FY2016 | $106.9M | 45.96% |
Quarterly newest first
| Period | Free cash flow | Change |
|---|---|---|
| Sep 2026 | $224.8M | 27.33% |
| Jun 2026 | $176.6M | 8.49% |
| Mar 2026 | $162.7M | (19.55%) |
| Dec 2025 | $202.3M | (0.93%) |
| 43 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| SNN Smith & Nephew SNATS, Inc. compare | $2.0B |
| GMED Globus Medical, Inc. | $766.6M |
| BIO.B Bio-Rad Laboratories, Inc. compare | $468.1M |
| BIO Bio-Rad Laboratories, Inc. compare | $468.1M |
| PODD Insulet Corporation compare | $260.0M |
| BRKR Bruker Corporation compare | $244.7M |
| PEN Penumbra, Inc. compare | $200.3M |
| TXG 10x Genomics compare | $121.4M |
| GKOS Glaukos Corporation compare | $36.0M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on GMED
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement